tilizing magnetic nanoparticles in prostate cancer for sentinel and aberrant lymph node mapping
Completed
- Conditions
- lymph node metastasesProstate cancer10027656
- Registration Number
- NL-OMON50068
- Lead Sponsor
- niversitieit Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Adults 18 years and older with a >=cT1N0M0 cinically significant prostate tumour
classification and who are scheduled for a prostatectomy
Exclusion Criteria
Contra-indications for robot assisted laparoscopy, intolerance/hypersensitivity
to iron or dextran compounds or Magtrace®, patients with an iron overload
disease, patients with pacemakers or other implantable devices in the chest
wall and/or lower body. Also prostate cancer patients without excessable rectum
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method